Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants

被引:32
作者
Puumalainen, T [1 ]
Zeta-Capeding, MR [1 ]
Käyhty, H [1 ]
Lucero, MG [1 ]
Auranen, K [1 ]
Leroy, O [1 ]
Nohynek, H [1 ]
机构
[1] Natl Publ Hlth Inst, Dept Vaccines, Helsinki 00300, Finland
关键词
pneumococcal; conjugate; vaccine; infants;
D O I
10.1097/00006454-200204000-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Pneumococcal conjugate vaccines are intended to provide effective protection against pneumococcal infections, but very little information on antibody responses in infants living in countries with high pneumococcal disease burden exists. Methods. In this study 50 healthy Filipino infants were enrolled at a village health center in Cabuyao to receive 11-valent diphtheria- and tetanus-conjugated pneumococcal vaccine at 6, 10 and 14 weeks of age (primary series) simultaneously with diphtheria-tetanus-whole cell pertussis/polyribosylribitol phosphate conjugated to tetanus toxoid, hepatitis B virus and oral poliovirus vaccines and at 9 months of age (booster dose) simultaneously with measles vaccine. The alum-adjuvanted study vaccine contained pneumococcal polysaccharide of serotypes 1, 4, 5, 7F, 9V, 19F and 23F conjugated to tetanus protein and pneumococcal polysaccharide of serotypes 3, 613, 14 and 18C conjugated to diphtheria toxoid. Serum samples for enzyme immunoassay analyses were collected at 6, 10 and 14 weeks and 9 and 10 months of age. Results. Very high geometric mean antibody concentrations (GMCs) against most pneumococcal serotypes were observed after the first three doses of vaccine (range, serotype 23F, 3.89 mug/ml to serotype 4, 23.41 mug/ml) with the exception of serotype 6B and 14, with GMCs of 1.12 and 2.18 mug/ml, respectively. The fourth dose increased the GMCs against most serotypes (range, serotype 14, 1.65 to serotype 19F, 33.43 mug/ml). The maternally derived antibodies did not decrease the response to the vaccine. Conclusions. This first pneumococcal conjugate vaccine study in Asia confirms that the 11-valent diphtheria- and tetanus-conjugated pneumococcal vaccine is highly immunogenic in Filipino infants. The GMCs against most pneumococcal serotypes were substantially higher than described with the same or other pneumococcal conjugate vaccines in other populations.
引用
收藏
页码:309 / 314
页数:6
相关论文
共 35 条
[1]   Streptococcus pneumonia capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory [J].
Åhman, H ;
Käyhty, H ;
Lehtonen, H ;
Leroy, O ;
Froeschle, J ;
Eskola, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) :211-216
[2]   Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid [J].
Åhman, H ;
Käyhty, H ;
Vuorela, A ;
Leroy, O ;
Eskola, J .
VACCINE, 1999, 17 (20-21) :2726-2732
[3]   Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants [J].
Ahman, H ;
Kayhty, H ;
Tamminen, P ;
Vuorela, A ;
Malinoski, F ;
Eskola, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (02) :134-139
[4]   Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants [J].
Anderson, EL ;
Kennedy, DJ ;
Geldmacher, KM ;
Donnelly, J ;
Mendelman, PM .
JOURNAL OF PEDIATRICS, 1996, 128 (05) :649-653
[5]   Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood [J].
Anttila, M ;
Eskola, J ;
Åhman, H ;
Käyhty, H .
VACCINE, 1999, 17 (15-16) :1970-1977
[6]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[7]  
CAPEDING MRZ, 2000, 9 INT C INF DIS BUEN
[8]   Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens [J].
Dagan, R ;
Melamed, R ;
Zamir, O ;
Leroy, O .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (11) :1053-1059
[9]   Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants [J].
Dagan, R ;
Eskola, J ;
Leclerc, C ;
Leroy, O .
INFECTION AND IMMUNITY, 1998, 66 (05) :2093-2098
[10]   Efficacy of a pneumococcal conjugate vaccine against acute otitis media [J].
Eskola, J ;
Kilpi, T ;
Palmu, A ;
Jokinen, J ;
Haapakoski, J ;
Herva, E ;
Takala, A ;
Käyhty, H ;
Karma, P ;
Kohberger, R ;
Siber, G ;
Mäkela, PH ;
Lockhart, S ;
Ecrola, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (06) :403-409